Genetic mutations are changes in the DNA sequence that can lead to the development of cancer. These mutations can result in the activation of oncogenes or the inactivation of tumor suppressor genes, ultimately leading to uncontrolled cell growth. Oncogenes often code for tyrosine kinases, which makes them a critical target for cancer therapies.
